Psychiatric Disorders Common in Juvenile Batten Disease, Study Finds
Most individuals with juvenile Batten disease meet the diagnostic criteria for at least one lifetime psychiatric disorder, according to recent research. A study focusing on families in Norway revealed a significant psychiatric burden in those affected by this rare neurodegenerative condition.
Understanding Juvenile Batten Disease
Juvenile Batten disease, also known as juvenile neuronal ceroid lipofuscinosis (JNCL) or CLN3 disease, is a genetic disorder that causes progressive neurological problems. Symptoms typically include vision loss, cognitive decline and behavioral challenges Batten Disease Family Association.
Prevalence of Psychiatric Diagnoses
The study, published in the Journal of Child Neurology, found that approximately 75% of the participants met the criteria for at least one psychiatric diagnosis. Around half of those studied had a current psychiatric disorder, with anxiety and neurodevelopmental disorders, particularly attention-deficit/hyperactivity disorder (ADHD), being the most prevalent Research Square.
Specifically, ten out of twenty patients met the criteria for at least one ongoing psychiatric diagnosis. Five additional patients had a history of psychiatric illness, primarily related to periods of depression. In total, fifteen of the twenty patients experienced a current or previous psychiatric diagnosis.
The Emergence of ADHD
Researchers noted the emergence of ADHD-like symptoms in some patients, even in the absence of a childhood history of the condition. This phenomenon, termed “secondary ADHD,” occurs when ADHD symptoms develop following the onset of another neurological condition. A case report detailed a 15-year-vintage boy with CLN3 who developed inattention, impulsivity, emotional dysregulation, and behavioral aggression, leading to a diagnosis of secondary ADHD Research Square.
Gaps in Mental Health Care
Despite the high prevalence of psychiatric issues, the study revealed that very few patients were receiving mental health care or psychotropic medications. Most had not been referred for specialized psychological support. This highlights a critical gap in the care provided to individuals with juvenile Batten disease.
The Need for Integrated Care
The researchers emphasize the need for multidisciplinary care that integrates psychiatric and neurological expertise. Routine screening for psychiatric symptoms, including even mild or “subthreshold” symptoms, is crucial for early identification and intervention. Stimulant treatment, such as methylphenidate, may be effective in managing secondary ADHD symptoms in selected adolescents with CLN3, as demonstrated in a recent case report Research Square.
Neurobehavioral Symptoms in Batten Disease
Neurobehavioral features are prominent in juvenile neuronal ceroid lipofuscinosis, encompassing intellectual decline, mood and behavioral impairments, and loss of adaptive skills National Center for Biotechnology Information. Understanding these neurobehavioral aspects is essential for a comprehensive understanding of the disease and for developing targeted interventions.
The researchers concluded that addressing the psychiatric comorbidity in individuals with CLN3 is critical to improving their overall health and functioning.